BAC
IBB icon

Boys Arnold & Co’s iShares Biotechnology ETF IBB Stock Holding History

Boys Arnold & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,990
Closed -$450K – 169
2015
Q4 		$450K Buy
3,990
+1,035
+35% +$112K 0.05% 205
2015
Q3 		$299K Buy
2,955
+165
+6% +$19.8K 0.06% 190
2015
Q2 		$343K Buy
+2,790
New +$334K 0.07% 182

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Boys Arnold & Co's IBB Position: Q1 2016 in Review

Boys Arnold & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 3,990 shares — an estimated $450K sold.

Boys Arnold & Co first reported a position in IBB in Q2 2015 and held it in 3 quarters. The position peaked at $450K in Q4 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

  • Boys Arnold & Co reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
  • Boys Arnold & Co sold 3,990 iShares Biotechnology ETF shares in Q1 2016, an estimated $450K.
  • Boys Arnold & Co first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 3 quarters.
  • Boys Arnold & Co's iShares Biotechnology ETF position peaked at $450K in Q4 2015.
  • 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Boys Arnold & Co's 13F filing for Q1 2016, filed 27 Apr 2016.